Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34472213

Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2022 Jan
First author
Getz KD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Getz KD
      type
      Author
    2. name
      Alonzo TA
      type
      Author
    3. name
      Sung L
      type
      Author
    4. name
      Meshinchi S
      type
      Author
    5. name
      Gerbing RB
      type
      Author
    6. name
      Raimondi S
      type
      Author
    7. name
      Hirsch B
      type
      Author
    8. name
      Loken M
      type
      Author
    9. name
      Brodersen LE
      type
      Author
    10. name
      Kahwash S
      type
      Author
    11. name
      Choi J
      type
      Author
    12. name
      Kolb EA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Getz KD
      type
      Author
    2. name
      Alonzo TA
      type
      Author
    3. name
      Sung L
      type
      Author
    4. name
      Meshinchi S
      type
      Author
    5. name
      Gerbing RB
      type
      Author
    6. name
      Raimondi S
      type
      Author
    7. name
      Hirsch B
      type
      Author
    8. name
      Loken M
      type
      Author
    9. name
      Brodersen LE
      type
      Author
    10. name
      Kahwash S
      type
      Author
    11. name
      Choi J
      type
      Author
    12. name
      Kolb EA
      type
      Author
    bibliography ids
    1. nci-bib-b36d3e90b1ce8e67e867a119
    book metadata
    content sha256
    e9ef535b86595f8a6cfb114adac7642c7ea7bc728ec19a18123d0953631a29e9
    document type
    citation
    dois
    1. 10.1002/pbc.29313
    electronic publication date
    display
    2021 Sep 2
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34472213
    immutable id
    pubmed:34472213@e9ef535b86595f8a6cfb114adac7642c7ea7bc728ec19a18123d0953631a29e9
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    1
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e29313
    volume
    69
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34472213
      provenance
      batch id
      192b6392c165c6b06274
      provider
      NCBI PubMed ESummary
      record sha256
      bdd3514448c546b20eacf197af0ab46ccfd61285d9b357b27dbd9d19b35c5930
      response sha256
      7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
      retrieved at
      2026-09-09T23:48:02.713075+00:00
      publication date
      display
      2022 Jan
      precision
      month
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34472213/
      title
      Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice